Liang Deng, MD, PhD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Kaposi sarcoma
- Melanoma of the skin
- Merkel cell carcinoma
My Specialties
- Prevention and early detection of melanoma in people with dysplastic nevi (moles)
- Diagnosis and management of skin cancer
- Oncodermatology
Get to Know Me
I am a board-certified dermatologist who specializes in the diagnosis and treatment of various skin conditions — particularly skin cancers including melanoma (the most dangerous form of skin cancer), genetic skin disorders, drug hypersensitivity reaction, therapy-induced skin toxicity, and skin manifestations of infections in immune-compromised individuals.
Most of the patients I care for have prior histories of skin cancers. I have several goals as their dermatologist: 1) to provide the best care possible for the treatment of their newly diagnosed skin cancers; 2) to examine their skin carefully in order to detect skin cancers at an early stage; and, 3) to educate them about sun protection and skin self-examination. Early detection of melanoma can save lives. For patients with many atypical moles and who carry high risks for developing melanoma, whole-body photography is a useful tool to assist dermatologists and patients to identify new or changing moles. I work closely with my colleagues on the melanoma disease management team, which is made up of doctors from medical oncology, clinical immunology, surgery, dermatology, and radiation oncology.
In my laboratory, we are studying the interface between poxviruses and the immune system in order to develop better therapies for poxviruses and harness the potential of poxviruses as oncolytic (cancer killing) and immunotherapeutic agents. I am also interested in understanding the role of apoptosis (programmed cell death) and autophagy (a stress response involving degradation of cellular contents) in the progression of melanoma and in its resistance to treatment. My research has been supported by the National Institutes of Health; Dermatology Foundation; Northeast Biodefense Center; American Skin Association; Lucille Castori Center for Microbes, Inflammation, and Cancer; and research funds from the Dermatology Service and the Department of Medicine at Memorial Sloan Kettering.
I also enjoy teaching and mentoring students, residents, and fellows in the clinic and in the laboratory. I am fluent in Mandarin Chinese.
I'm a dermatologist, which is a doctor with special training in skin, hair, and nails.
- Associate Attending Physician
Conditions I Treat
- Kaposi sarcoma
- Melanoma of the skin
- Merkel cell carcinoma
- Angiosarcoma (ANGS)
- Atypical moles
- Basal cell carcinomas of the skin
- Congenital nevi (moles)
- Genetic skin disorders
- Lentigo maligna melanoma (LMM)
- Non-melanoma skin cancer
- Rare skin cancers
- Skin cancer and conditions
- Squamous cell carcinoma of the skin
My Specialties
- Prevention and early detection of melanoma in people with dysplastic nevi (moles)
- Diagnosis and management of skin cancer
- Oncodermatology
- Non-surgical treatment of skin cancer
- Dermatologic symptoms and side effects
Education
- MD, Weill Cornell Medical College
Residencies
- Dermatology - New York Presbyterian/Weill Cornell Medical Center
Board Certifications
- Dermatology
Awards and Honors
- Castle Connolly: America’s Top Doctor (2025)
- Castle Connolly: Top AAPI Doctor (2024)
- Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Deng sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Liang Deng discloses the following relationships and financial interests:
-
Immunogenesis, Inc.
Intellectual Property Rights
-
Imvaq Therapeutics
Equity; Intellectual Property Rights; Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].